Clinical Trials
2 trialsNCT05722795 2025-07-09
I-CONIC
Vastra Gotaland Region
Phase NA Recruiting
NCT06229067 2024-01-29
Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting